Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04541251
Status:
UNKNOWN
Last Update Posted:
2021-06-23
First Post:
2020-02-09
Brief Title:
Neoadjuvant Camrelizumab Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization Data
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Class:
OTHER
Study ID:
2020-KY-061-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor Class:
OTHER
Responsible Party:
Herui Yao
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Guangdong Provincial Peoples Hospital | OTHER |
| Third Affiliated Hospital Sun Yat-Sen University | OTHER |